CD274 and head and neck squamous cell carcinoma: Studies place HNSCC amongst the malignancies with the highest frequency of PD-L1 positivity, defined as PD-L1 expression ≥ 1% when measured by either tumor proportion score (TPS) or combined positive score (CPS).